Data from Lenad III shows that cannabis use among women has grown significantly in Brazil over the last decade, with a focus on adolescents and changes in consumption patterns

NBER study indicates that access to recreational cannabis, through the opening of dispensaries, is associated with a reduction in suicide rates among older adults in the US

Trump states he does not intend to use medical cannabis, but acknowledges that the substance can be an alternative to opioids and necessary for many patients

Planning to travel at the end of the year and using medical cannabis? Learn about the required documents, how to transport the medication, and what precautions to take in Brazil and abroad

The event brings together health, science, industry, and agribusiness experts to discuss advances, regulatory challenges, and the future of medicinal cannabis and industrial hemp in Brazil.

Moving from Schedule I to Schedule III could unlock research, ease tax hurdles, and impact state markets

According to Marcelo Polacow Bisson, excluding pharmacies' manipulation leads to lack of assistance; Anvisa's proposed text on the Cannabis regulation is also criticized for bypassing procedural rites

Proposal in the review of RDC 327/2019 to RDC 660/2022 divides opinions and raises doubts about access and judicialization

Doctor Beatriz Milani explains how the principle “Start low, go slow” guides the safe and personalized use of medical cannabis, ensuring careful adjustments and the lowest effective dose for each patient

Partnership between laboratories materializes the legal sale of finished pharmaceutical product, consolidating Morocco's entry into the international market

Publication presented in London fills gaps in professional training and provides safety guidelines for prescribing cannabis oils in 12 clinical conditions

German upper house approves changes to MedCanG on prescriptions and advertising, but rejects penalties for postal delivery

2025 Yearbook shows treatment expansion, prescribers scenario, and an approximate revenue of R$ 1 billion

Initiative by Alesp includes proposals focused on health and research with medical cannabis from two third sector entities, two municipal governments, and one state administration agency

Initiative creates unprecedented database to analyze the quality of oils from patient associations and boost clinical trials in Brazil

Initiative creates unprecedented database to analyze the quality of oils from patient associations and boost clinical trials in Brazil

Tickets for the first batch of the Brazilian Medicinal Cannabis Congress are still available for R$ 540.00; turnover to the second batch takes place on December 16

Preventive action involves imported and national items and reinforces rules for restricted disclosure to doctors and pharmacists

Measure published in the Official Gazette affects company; resolution prohibits sale of Cannabis products without sanitary registration